Guanylate-binding protein 1 participates in cellular antiviral response to dengue virus

Virology Journal

Volumn 9, Issue , 2012, Pages

  Pan, Wen ^a   Zuo, Xiangyang ^a   Feng, Tingting ^a   Shi, Xiaohong ^a   Dai, Jianfeng ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Antiviral response; DENV; GBP1; NF B

Indexed keywords

BINDING PROTEIN; GUANYLATE BINDING PROTEIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DENGUE; DENGUE VIRUS; GENE; GENE SILENCING; GUANYLATE BINDING PROTEIN 1 GENE; IN VITRO STUDY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VIRUS LOAD; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CYTOKINES; DENGUE VIRUS; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; HUMANS; MACROPHAGES; MICE; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSCRIPTOME;

DENGUE VIRUS; MOSQUITO-BORNE VIRUSES;

EID: 84869877631     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-292     Document Type: Article

References (28)

1. The pathogenesis of dengue. Whitehorn J, Simmons CP, Vaccine 2011 29 7221 7228 10.1016/j.vaccine.2011.07.022 21781999
2. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Gubler DJ, Trends Microbiol 2002 10 100 103 10.1016/S0966-842X(01)02288-0 11827812
3. Immune response to dengue virus and prospects for a vaccine. Murphy BR, Whitehead SS, Annu Rev Immunol 2011 29 587 619 10.1146/annurev-immunol-031210- 101315 21219187
4. Pathogenesis of flavivirus infections: using and abusing the host cell. Fernandez-Garcia MD, Mazzon M, Jacobs M, Amara A, Cell Host Microbe 2009 5 318 328 10.1016/j.chom.2009.04.001 19380111
5. Heterotypic dengue infection with live attenuated monotypic dengue virus vaccines: implications for vaccination of populations in areas where dengue is endemic. Durbin AP, Schmidt A, Elwood D, Wanionek KA, Lovchik J, Thumar B, Murphy BR, Whitehead SS, J Infect Dis 2011 203 327 334 10.1093/infdis/jiq059 21208923
6. Induction and regulation of IFNs during viral infections. Malmgaard L, J Interferon Cytokine Res 2004 24 439 454 10.1089/1079990041689665 15320958
7. The JAK/STAT signaling pathway. Rawlings JS, Rosler KM, Harrison DA, J Cell Sci 2004 117 1281 1283 10.1242/jcs.00963 15020666
8. Mechanisms of type-I- and type-II-interferon-mediated signalling. Platanias LC, Nat Rev Immunol 2005 5 375 386 10.1038/nri1604 15864272
9. Interferon induction of fibroblast proteins with guanylate binding activity. Cheng YS, Colonno RJ, Yin FH, J Biol Chem 1983 258 7746 7750 6305951
10. Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Prakash B, Praefcke GJ, Renault L, Wittinghofer A, Herrmann C, Nature 2000 403 567 571 10.1038/35000617 10676968
11. In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. Olszewski MA, Gray J, Vestal DJ, J Interferon Cytokine Res 2006 26 328 352 10.1089/jir.2006.26.328 16689661
12. Emerging themes in IFN-gamma-induced macrophage immunity by the p47 and p65 GTPase families. Shenoy AR, Kim BH, Choi HP, Matsuzawa T, Tiwari S, MacMicking JD, Immunobiology 2007 212 771 784 18086378
13. IFN-inducible GTPases and immunity to intracellular pathogens. MacMicking JD, Trends Immunol 2004 25 601 609 10.1016/j.it.2004.08.010 15489189
14. Human guanylate binding protein-1 (hGBP-1) characterizes and establishes a non-angiogenic endothelial cell activation phenotype in inflammatory diseases. Naschberger E, Bauer M, Sturzl M, Adv Enzyme Regul 2005 45 215 227 10.1016/j.advenzreg.2005.02.011 16005050
15. Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. Lubeseder-Martellato C, Guenzi E, Jorg A, Topolt K, Naschberger E, Kremmer E, Zietz C, Tschachler E, Hutzler P, Schwemmle M, et al. Am J Pathol 2002 161 1749 1759 10.1016/S0002-9440(10)64452-5 12414522
16. Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis. Schnoor M, Betanzos A, Weber DA, Parkos CA, Mucosal Immunol 2009 2 33 42 10.1038/mi.2008.62 19079332
17. A family of IFN-gamma-inducible 65-kD GTPases protects against bacterial infection. Kim BH, Shenoy AR, Kumar P, Das R, Tiwari S, MacMicking JD, Science 2011 332 717 721 10.1126/science.1201711 21551061
18. Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma. Tietzel I, El-Haibi C, Carabeo RA, PLoS One 2009 4 6499 10.1371/journal.pone.0006499 19652711
19. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Anderson SL, Carton JM, Lou J, Xing L, Rubin BY, Virology 1999 256 8 14 10.1006/viro.1999.9614 10087221
20. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. Itsui Y, Sakamoto N, Kurosaki M, Kanazawa N, Tanabe Y, Koyama T, Takeda Y, Nakagawa M, Kakinuma S, Sekine Y, et al. J Viral Hepat 2006 13 690 700 10.1111/j.1365-2893.2006.00732.x 16970601
21. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Itsui Y, Sakamoto N, Kakinuma S, Nakagawa M, Sekine-Osajima Y, Tasaka-Fujita M, Nishimura-Sakurai Y, Suda G, Karakama Y, Mishima K, et al. Hepatology 2009 50 1727 1737 10.1002/hep.23195 19821486
22. ISG15 facilitates cellular antiviral response to dengue and west nile virus infection in vitro. Dai J, Pan W, Wang P, Virol J 2011 8 468 10.1186/1743-422X-8-468 21992229
23. Characterization of early host responses in adults with dengue disease. Tolfvenstam T, Lindblom A, Schreiber MJ, Ling L, Chow A, Ooi EE, Hibberd ML, BMC Infect Dis 2011 11 209 10.1186/1471-2334-11-209 21810247
24. The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults. Hoang LT, Lynn DJ, Henn M, Birren BW, Lennon NJ, Le PT, Duong KT, Nguyen TT, Mai LN, Farrar JJ, et al. J Virol 2010 84 12982 12994 10.1128/JVI.01224-10 20943967
25. Nuclear receptors versus inflammation: mechanisms of transrepression. Pascual G, Glass CK, Trends Endocrinol Metab 2006 17 321 327 10.1016/j.tem.2006.08.005 16942889
26. Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Ivashkiv LB, Eur J Immunol 2011 41 2477 2481 10.1002/eji.201141783 21952800
27. Infection of human cells by dengue virus is modulated by different cell types and viral strains. Diamond MS, Edgil D, Roberts TG, Lu B, Harris E, J Virol 2000 74 7814 7823 10.1128/JVI.74.17.7814-7823.2000 10933688
28. The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. Guenzi E, Topolt K, Cornali E, Lubeseder-Martellato C, Jorg A, Matzen K, Zietz C, Kremmer E, Nappi F, Schwemmle M, et al. EMBO J 2001 20 5568 5577 10.1093/emboj/20.20.5568 11598000